Skip to main content
SpringerLink
Log in

The effect of zidovudine on chronic myelopathy associated with HTLV-1

  • Letters To The Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gessain A, Saal F, Gout O, Daniel MT, Flandrin G, Thé G de, Périès J, Sigaux F (1990) High human T-cell lymphotropic virus type 1 proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese and African patients with tropical spastic paraparesis. Blood 75:428–433

    Google Scholar 

  2. Gout O, Baulac M, Gessain A, Semah F, Saal F, Périès J, Cabrol C, Foucault-Fretz C, Laplane D, Thé G de (1990) Rapid development of myelopathy after HTLV-1 infection acquired by transfusion during cardiac transplantation. N Engl J Med 322:383–388

    Google Scholar 

  3. Matsushita S, Mitsuya H, Reitz MS, Broder S (1987) Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type 1. J Clin Invest 80:393–400

    Google Scholar 

  4. Roman G, Vernant JC, Osame M (eds) (1989) HTLV-1 and the nervous system. (Neurology and neurobiology, vol 51), Liss, New York

    Google Scholar 

  5. Tendler CJ, Greenberg SJ, Blattner WA, Manns A, Murphy E, Fleisher T, Hanchard B, Morgan O, Burton JD, Nelson DL, Waldmann TA (1990) Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type 1-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 87:5218–5222

    Google Scholar 

Download references

Author information

Author notes

  1. O. Gout

    Present address: Laboratory of Viral and Molecular Pathogenesis, National Institute of Neurological Disorders and Stroke, Building 36, Room 5DO4, 20892, Bethesda, MD, USA

Authors and Affiliations

  1. Department of Neurology, Hôpital de la Salpétrière, 47, Boulevard de l'Hôpital, F-75013, Paris, France

    O. Gout, F. Bolgert & O. Lyon-Caen

  2. Laboratory of Epidemiology and Immunovirology of Tumours, Faculté de Médecine Alexis Carrel, Rue G. Parradin, F-69372, Lyon, France

    A. Gessain & G. de Thé

  3. Department of Radiology, Hôpital des Quinze-Vingts, F-75011, Paris, France

    Mt. Iba-Zizen

  4. Wellcome Laboratory, 159, Rue Nationale, F-75013, Paris, France

    S. Kouzan

Authors
  1. O. Gout
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gessain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mt. Iba-Zizen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Kouzan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Bolgert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. de Thé
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. Lyon-Caen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gout, O., Gessain, A., Iba-Zizen, M. et al. The effect of zidovudine on chronic myelopathy associated with HTLV-1. J Neurol 238, 108–109 (1991). https://doi.org/10.1007/BF00315691

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315691

Keywords

Search

Navigation